🔗 Share this article

The prestigious award in medical science has been granted for revolutionary discoveries that illuminate how the immune system targets dangerous pathogens while sparing the healthy tissues.

Three renowned researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

The work uncovered specialized "security guards" within the defense system that remove rogue defense cells capable of attacking the body.

These findings are now paving the way for innovative therapies for immune disorders and cancer.

These winners will share a monetary award worth 11 million Swedish kronor.

Decisive Findings

"Their research has been essential for comprehending how the body's defenses functions and the reason we don't all suffer from severe self-attack conditions," commented the head of the Nobel Committee.

This team's research address a core question: In what way does the defense system protect us from countless infections while leaving our own tissues unharmed?

The body's protection system uses immune cells that search for indicators of infection, even viruses and germs it has never encountered.

These cells employ detectors—called recognition units—that are generated by chance in a vast number of combinations.

That provides the immune system the ability to combat a wide array of threats, but the randomness of the process inevitably creates white blood cells that may target the body.

Security Guards of the Body

Researchers earlier understood that some of these harmful white blood cells were eliminated in the thymus—the site where immune cells mature.

The latest award recognizes the discovery of regulatory T-cells—described as the body's "security guards"—which patrol the system to disarm other immune cells that assault the healthy cells.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.

The prize committee added, "These findings have established a new field of investigation and accelerated the development of new treatments, for example for tumors and autoimmune diseases."

In malignancies, regulatory T-cells block the body from fighting the growth, so studies are focused on lowering their numbers.

For autoimmune diseases, trials are testing boosting T-reg cells so the body is not being harmed. A comparable method could also be effective in reducing the chances of transplanted organ failure.

Innovative Experiments

Professor Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their thymus removed, leading to self-attack conditions.

He demonstrated that injecting immune cells from healthy animals could prevent the disease—suggesting there was a system for blocking immune cells from harming the body.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited immune disorder in rodents and people that resulted in the discovery of a gene critical for how regulatory T-cells function.

"Their groundbreaking research has revealed how the immune system is controlled by T-reg cells, stopping it from mistakenly targeting the healthy cells," commented a leading physiology expert.

"The work is a striking example of how basic physiological study can have far-reaching consequences for human health."